Travere Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $894k | 99k | 8.99 |
| 2023-09-30 | $889k | 99k | 8.94 |
| 2023-06-30 | $2.0M | 89k | 22.49 |
| 2023-03-31 | $2.0M | 89k | 22.49 |
| 2022-12-31 | $1.3M | 64k | 21.03 |
| 2022-09-30 | $1.5M | 62k | 24.64 |
| 2022-06-30 | $1.6M | 66k | 24.23 |
| 2022-03-31 | $1.7M | 67k | 25.77 |
| 2021-12-31 | $2.0M | 63k | 31.04 |
| 2021-09-30 | $1.3M | 52k | 24.25 |
| 2021-06-30 | $781k | 54k | 14.59 |
| 2021-03-31 | $1.2M | 49k | 24.97 |
| 2020-12-31 | $1.1M | 39k | 27.26 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas